InvestorsHub Logo
Followers 118
Posts 11972
Boards Moderated 0
Alias Born 12/18/2003

Re: theswordman post# 206183

Saturday, 03/26/2022 7:05:36 AM

Saturday, March 26, 2022 7:05:36 AM

Post# of 232961
I also had a contact with Dr Lalezari in the past .,
And for CD12 CYDY proposed 4 doses not 2 ,
This was already established many times . Dr Lalezari was never comfortable with 2 doses only for severe and critical patients , this is why this is a first thing he asked DSMC during interim results , is the dose ok , or maybe more doses needed for this patients ., and what was the answer ,
all is very good , don’t change anything ..
Why was that ? When a kindergarten child could recognized from the results that drug working great but more doses needed .

Why DSMC didn’t tell them the truth !!!!

And why FDA without any reason changed CYDY protocol to 2 injections , and gave them 28 days mortality as a primary endpoint ..
FDA most probably know , or they should know , that half life of Leronlimab when given SC is 10 days , so this change is without explanation .,
FDA should also know by then that people using weekly doses of Leronlimab for HIV for years by then , without any serious side effects.,

So this action of FDA is very suspicious and it look like intentional sabotage by FDA of this study ..
But we know now from the Veritas video with FDA executive …
” vaccines must be mandate “ , so look that they must not approve a good drug ..

All imo .,


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News